Lumisys turns profit despite dip in revenuesRevenues at Lumisys declined 24% during the company's second quarter. For the period (end-June), revenues were $5.4 million, compared with $7.2 million last year. The firm did post a profit of $62,000,
Revenues at Lumisys declined 24% during the company's second quarter. For the period (end-June), revenues were $5.4 million, compared with $7.2 million last year. The firm did post a profit of $62,000, however, compared with a net loss of $141,000 in 1997. Company executives believe the financial performance will improve going forward.
In other news, Lumisys has completed a beta test for its ACR-2000 CR system (PNN 6/98)
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.